Compare NHTC & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NHTC | IXHL |
|---|---|---|
| Founded | 1988 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 97.6M |
| IPO Year | 1999 | 2024 |
| Metric | NHTC | IXHL |
|---|---|---|
| Price | $3.19 | $5.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.5K | ★ 4.1M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 12.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,776,000.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.40 | $0.11 |
| 52 Week High | $5.48 | $5.45 |
| Indicator | NHTC | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 40.06 | 90.18 |
| Support Level | $2.99 | $0.31 |
| Resistance Level | $3.07 | N/A |
| Average True Range (ATR) | 0.14 | 0.37 |
| MACD | -0.01 | 0.40 |
| Stochastic Oscillator | 13.16 | 91.05 |
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and support active, physical, and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and the rest from China, Taiwan, Japan, the United States, and other regions.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.